Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

News Conference News AHA 2017

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

Shelley Wood

November 09, 2017

Presentation TCT 2017

CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Francisco Fdez-Aviles

October 31, 2017

Presentation TCT 2017

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Timothy D. Henry

October 31, 2017

News Daily News

WhatsApp Enables Swift Diagnosis of STEMI and Cath Lab Activation

Yael L. Maxwell

October 27, 2017

News Features

Getting High: The Low-down for Cardiologists on Illicit Drugs and Marijuana

Ashley Lyles

July 13, 2017

News Daily News

Biomedical Research in CVD: More Investment Today Will Yield Long-term Rewards

Caitlin E. Cox

June 29, 2017

$Access Denied: Stem Cell Therapy Shows Some Promise in Refractory Angina, but Patients Can’t Get It$

News Conference News SCAI 2017

Access Denied: Stem Cell Therapy Shows Some Promise in Refractory Angina, but Patients Can’t Get It

L.A. McKeown

May 19, 2017

News Industry News

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

May 05, 2017

News Opinion Fellow Talk

Navigating and Negotiating Your First Job Contract

Rahul Sharma, MD

April 11, 2017

News Daily News

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

Yael L. Maxwell

February 22, 2017

Advertisement

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

WhatsApp Enables Swift Diagnosis of STEMI and Cath Lab Activation

Getting High: The Low-down for Cardiologists on Illicit Drugs and Marijuana

Biomedical Research in CVD: More Investment Today Will Yield Long-term Rewards

Access Denied: Stem Cell Therapy Shows Some Promise in Refractory Angina, but Patients Can’t Get It

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

Navigating and Negotiating Your First Job Contract

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content